Selutaront is a trace amine-associated receptor 1 (TAAR1) agonist which is being investigated for the potential treatment of schizophrenia. It is a highly selective, low-potency, high-efficacy partial agonist of the human TAAR1 (EC50 = 2,330nM; Emax = 83%).
The compounds of every Wikipedia article carrying a Chembox or a Drugbox, refreshed daily, with the values their infoboxes give. The pages need JavaScript; the API does not.